MJMuriel Rejane Jacquier-Sarlin

Muriel Rejane Jacquier-Sarlin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Muriel Rejane Jacquier-Sarlin has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Alain Buisson

    Univ. Grenoble Alpes Inserm U1216

    6 shared publications
  • Barbara S. Polla

    5 shared publications
  • Benjamin Ducarouge

    Benjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France

    4 shared publications
  • Marc.R. Block

    Institut Albert Bonniot, Institut National de la Santé et de la Recherche Médicale U823, 38042 Grenoble, France Université Grenoble Alpes, 38400 Saint-Martin-d'Hères, France Equipe de Recherche Labellisée, Centre National de la Recherche Scientifique 5284, 38042 Grenoble, France

    4 shared publications
  • Nicolas T. Chartier

    TU Dresden

    4 shared publications
  • B. S. Polla

    Laboratoire de Biologie, Physiologie et Pathologie de la Respiration, UFR Cochin Port-Royal, 24 rue du Faubourg, Saint-Jacques, Université René Descartes, F-75014 Paris (France), Fax +33 1 44 41 23 33 , FR

    3 shared publications

Latest Publications

  • Open Access

    The Gut-Brain Homeostatic Continuum in Alzheimer’s disease: a systems framework for physiological resilience and disease progression

    by Muriel Jacquier-Sarlin, Maxime Seignobos, Louis Rauzier, Béatrice Schaack, David Laurin, Alain Buisson

    The gut-brain axis has substantially improved our understanding of Alzheimer’s disease (AD) by highlighting the complex bidirectional interactions between the gastrointestinal tract, the microbiota and the central nervous system. Nevertheless, this framework does not fully explain why brain and organismal homeostasis can be maintained for decades despite the continuous and cumulative burden of aging, genetic susceptibility and environmental stressors, or why this resilience ultimately fails in some individuals. In this review, we propose the Gut-Brain Homeostatic Continuum (GBHC), a conceptual framework that extends the classical gut-brain axis into a dynamic, interconnected system of layered homeostatic mechanisms. Rather than viewing gut-brain interactions as parallel signaling routes, the GBHC emphasizes how the preservation of intestinal and blood-brain barrier integrity supports coordinated immune, metabolic and inter-organ regulation, which in turn contributes to systemic proteostasis and the trafficking and clearance of proteins. Through these interconnected processes, peripheral physiological states may influence the capacity of the brain to maintain homeostasis and resilience. Within this framework, AD is viewed as a progressive erosion of organismal resilience rather than the consequence of a single pathological pathway. We discuss how aging, genetic factors and the exposome may progressively challenge interconnected regulatory mechanisms, weakening the capacity to preserve homeostasis and increasing vulnerability to neurodegeneration. This perspective also suggests a complementary approach to biomarker discovery, focusing on multimodal signatures that capture biological trajectories and changes in regulatory capacity. Such signatures could integrate markers of barrier integrity and permeability, immune and metabolic regulation, microbial and host-derived metabolites, extracellular vesicle cargo, and proteostasis-related proteins, including established markers of neurodegeneration such as amyloid-β, phosphorylated tau and neurofilament light chain. Although several aspects of the GBHC remain hypothetical and require experimental validation, this framework provides an integrative model that complements current concepts of AD pathogenesis and opens new perspectives for multidisciplinary research and therapeutic innovation.

  • Open Access

    Fecal ATX(N) profiling reveals early genotype-associated molecular signatures in APP/PS1 mice

    by Maxime Seignobos, Sylvie Boisseau, Frédérique Vossier, Louis Rauzier, Alain Buisson, Muriel Jacquier-Sarlin

    Reliable and minimally invasive approaches for studying Alzheimer’s disease (AD)-associated molecular changes are needed. Fecal material represents an accessible biological matrix that may contain molecular information associated with systemic or gastrointestinal processes linked to disease-related phenotypes. Here, we investigated whether ATX(N)-related immunoreactivities can be detected in fecal extracts from APP/PS1 mice and whether their levels differ from wild-type (WT) controls at age-defined stages of amyloid-driven pathology. Fecal samples were collected from independent cohorts of WT and APP/PS1 mice at 1 and 6 months of age and analyzed using semi-quantitative Western blot and dot blot assays targeting amyloid-β, total Tau, phosphorylated Tau, neurodegeneration-associated, synaptic, and inflammatory markers. Exploratory ROC analyses were performed to assess discrimination between APP/PS1 and WT mice. Pre-analytical stability was evaluated under prolonged storage and repeated freeze–thaw conditions. Cerebral amyloid and plaque-associated Tau pathology were characterized histologically at 3, 6, and 9 months. Aβ-, Tau-, phosphorylated Tau-, NfL-, synaptic-, and inflammation-associated immunoreactivities were detectable in fecal extracts. At 1 month, APP/PS1 mice showed increased fecal levels of several Aβ and phosphorylated Tau immunoreactivities, as well as NfL and synaptophysin, compared with WT mice. Exploratory ROC analyses indicated discriminatory capacity for several markers at 1 month, including Aβ42 and pTauThr181, whereas Iba1 showed the highest AUC estimate at 6 months. Selected fecal immunoreactivities remained relatively stable under the tested storage and freeze–thaw conditions. These findings support the feasibility of detecting multiple ATX(N)-related immunoreactivities in fecal extracts from APP/PS1 mice and identify genotype-associated molecular differences at early and later stages of amyloid-driven pathology.


  • Open Access

    Biological matrix determines the performance of UV-induced fluorescence for protein normalization in dot blot assays

    by Louis Rauzier, Patrick Meresse, Maxime Seignobos, Alain Buisson, Muriel Rejane Jacquier-Sarlin

    Protein normalization is essential for quantitative membrane-based protein assays, yet conventional staining methods remain time-consuming and may introduce experimental variability. UV-induced fluorescence (UV-IF) has emerged as a rapid, non-destructive alternative, but its analytical performance across biological matrices has not been systematically evaluated. Because UV-IF relies on intrinsic protein fluorescence rather than dye binding, we hypothesized that its performance is matrix dependent.We compared UV-IF with Amido Black and Ponceau S for total protein quantification on nitrocellulose membranes using dot blots. Using BCA-normalized human fecal protein extracts, we assessed analytical sensitivity, linearity, precision, inter-assay reproducibility, storage stability and resistance to repeated freeze-thaw cycles. Purified proteins and biological matrices were analyzed to investigate matrix dependency.UV-IF performance varied across biological matrices. Strong fluorescence signals were observed in human and murine fecal protein extracts, whereas plasma, urine and several tissue or cell extracts generated weak fluorescence despite equivalent loading. Within fecal samples, Amido Black showed greater sensitivity at low protein loads, whereas UV-IF provided a broader linear range, comparable analytical precision, superior inter-assay reproducibility and greater robustness during storage and repeated freeze-thaw cycles. Ponceau S failed to provide reliable protein quantification.This study demonstrates that UV-IF is a biological matrix-dependent method for total protein normalization rather than a universal membrane protein detection approach. Our findings highlight the importance of matrix-specific analytical validation before implementing UV-IF in new biological applications. When applied to fecal protein extracts, UV-IF provides a rapid, non-destructive and highly reproducible strategy for total protein normalization in high-throughput dot blot assays.

  • Open Access

    Vers l’utilisation des pseudo-prions contre les maladies neurodégénératives

    by Marc Dhenain, Marina Celestine, Muriel Jacquier-Sarlin, Alain Buisson

    Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé

  • Open Access

    Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model

    by Marina Célestine, Muriel Jacquier-Sarlin, Eve Borel, Fanny Petit, Fabien Lante, Luc Bousset, Anne-Sophie Hérard, Alain Buisson, Marc Dhenain

    The amyloid cascade hypothesis assumes that the development of Alzheimer’s disease (AD) is driven by a self-perpetuating cycle, in which β-amyloid (Aβ) accumulation leads to Tau pathology and neuronal damages. A particular mutation (A673T) of the amyloid precursor protein (APP) was identified among Icelandic population. It provides a protective effect against Alzheimer- and age-related cognitive decline. This APP mutation leads to the reduced production of Aβ with A2T (position in peptide sequence) change (Aβice). In addition, Aβice has the capacity to form protective heterodimers in association with wild-type Aβ. Despite the emerging interest in Aβice during the last decade, the impact of Aβice on events associated with the amyloid cascade has never been reported. First, the effects of Aβice were evaluated in vitro by electrophysiology on hippocampal slices and by studying synapse morphology in cortical neurons. We showed that Aβice protects against endogenous Aβ-mediated synaptotoxicity. Second, as several studies have outlined that a single intracerebral administration of Aβ can worsen Aβ deposition and cognitive functions several months after the inoculation, we evaluated in vivo the long-term effects of a single inoculation of Aβice or Aβ-wild-type (Aβwt) in the hippocampus of transgenic mice (APPswe/PS1dE9) over-expressing Aβ1-42 peptide. Interestingly, we found that the single intra-hippocampal inoculation of Aβice to mice rescued synaptic density and spatial memory losses four months post-inoculation, compared with Aβwt inoculation. Although Aβ load was not modulated by Aβice infusion, the amount of Tau-positive neuritic plaques was significantly reduced. Finally, a lower phagocytosis by microglia of post-synaptic compounds was detected in Aβice-inoculated animals, which can partly explain the increased density of synapses in the Aβice animals. Thus, a single event as Aβice inoculation can improve the fate of AD-associated pathology and phenotype in mice several months after the event. These results open unexpected fields to develop innovative therapeutic strategies against AD.


  • Open Access

    CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway

    by Benoît Boulan, Charlotte Ravanello, Amandine Peyrel, Christophe Bosc, Christian Delphin, Florence Appaix, Eric Denarier, Alexandra Kraut, Muriel Jacquier-Sarlin, Alyson Fournier, et al.

    Neurodevelopmental axonal pathfinding plays a central role in correct brain wiring and subsequent cognitive abilities. Within the growth cone, various intracellular effectors transduce axonal guidance signals by remodeling the cytoskeleton. Semaphorin-3E (Sema3E) is a guidance cue implicated in development of the fornix, a neuronal tract connecting the hippocampus to the hypothalamus. Microtubule-associated protein 6 (MAP6) has been shown to be involved in the Sema3E growth-promoting signaling pathway. In this study, we identified the collapsin response mediator protein 4 (CRMP4) as a MAP6 partner and a crucial effector in Sema3E growth-promoting activity. CRMP4-KO mice displayed abnormal fornix development reminiscent of that observed in Sema3E-KO mice. CRMP4 was shown to interact with the Sema3E tripartite receptor complex within detergent-resistant membrane (DRM) domains, and DRM domain integrity was required to transduce Sema3E signaling through the Akt/GSK3 pathway. Finally, we showed that the cytoskeleton-binding domain of CRMP4 is required for Sema3E’s growth-promoting activity, suggesting that CRMP4 plays a role at the interface between Sema3E receptors, located in DRM domains, and the cytoskeleton network. As the fornix is affected in many psychiatric diseases, such as schizophrenia, our results provide new insights to better understand the neurodevelopmental components of these diseases.


  • Heat Shock Proteins in Eosinophilic Inflammation

    by Pandora Christie, Muriel R. Jacquier-Sarlin, Anne Janin, Jean Bousquet, Barbara S. Polla

    Eosinophils are so-called because of their strong affinity for the acidic dye eosin, which is related to their content in highly toxic basic proteins. Major basic protein is located in the core of the granules, whereas eosinophil cationic proteins, eosinophil-derived neurotoxin, and eosinophil peroxidase are located in their matrix. The role of hsps in parasitic disease has been reviewed elsewhere. The initial change in temperature experienced by the parasite may induce heat shock protein (hsp) synthesis. Hsps may interfere with parasite recognition and infectivity, differentiation, and resistance. The induction of hsps during some, but not other, forms of eosinophilic inflammation and the links between eosinophilia, the severity of inflammation, and the presence of hsps, suggest that hsps could represent new clinical markers for eosinophilic inflammation. The induction of hsps as observed in eosinophilic inflammation within the lung likely deserves such protective functions.

  • Open Access

    Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation

    by Travis Rush, Jose Martinez-Hernandez, Marc Dollmeyer, Marie Lise Frandemiche, Eve Borel, Sylvie Boisseau, Muriel Jacquier-Sarlin, Alain Buisson

    Amyloid-β (Aβ) drives the synaptic impairment and dendritic spine loss characteristic of Alzheimer's disease (AD), but how Aβ affects the actin cytoskeleton remains unknown and contentious. The actin-binding protein, cofilin-1 (cof1), is a major regulator of actin dynamics in dendritic spines, and is subject to phospho-regulation by multiple pathways, including the Rho-associated protein kinase (ROCK) pathway. While cof1 is implicated as a driver of the synaptotoxicity characteristic of the early phases of AD pathophysiology, questions remain about the molecular mechanisms involved. Cofilin-actin rods are observed in neurons exposed to Aβ oligomers (Aβo) and in tissue from AD patients, and others have described an increased cofilin phosphorylation (p-cof1) in AD patients. Here, we report elevated p-cof1 of the postsynaptic enriched fraction of synaptosomes from cortical samples of male APP/PS1 mice and human AD cases of either sex. In primary cortical neurons, Aβo induced rapid actin stabilization and increased p-cof1 in the postsynaptic compartment of excitatory synapses within 30 min. Fluorescence recovery after photobleaching of actin-GFP and calcium imaging in live neurons expressing active or inactive cof1 mutants suggest that cof1 phosphorylation is necessary and sufficient for Aβo-induced synaptic impairment via actin stabilization before the reported formation of cofilin-actin rods. Moreover, the clinically available and well-tolerated ROCK inhibitor, fasudil, prevented Aβo-induced actin stabilization, synaptic impairment, and synaptic loss by blocking cofilin phosphorylation. Aβo also blocked the LTP-induced insertion of the AMPAR subunit, GluA1, at the postsynaptic density, in a fasudil-sensitive manner. These data support an important role for ROCKs and cofilin in mediating Aβ-induced synaptic impairment.SIGNIFICANCE STATEMENTWe report that amyloid-β oligomers rapidly induce aberrant stabilization of F-actin within dendritic spines, which impairs synaptic strength and plasticity. Activation of the Rho-associated protein kinase (ROCK) pathway results in phosphorylation of cof1 and is sufficient to mediate Aβo-induced actin stabilization synaptic impairment and synaptic loss. Further, the ROCK inhibitor, fasudil, prevents cofilin phosphorylation, acute synaptic disruption, and synaptotoxicity in primary cortical neurons. Together, the herein presented data provide strong support for further study of the ROCK pathway as a therapeutic target for the cognitive decline and synaptotoxicity in Alzheimer's disease.


  • Open Access

    TRPA1 channels promote astrocytic Ca2+ hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid-β peptide

    by Anthony Bosson, Adrien Paumier, Sylvie Boisseau, Muriel Jacquier-Sarlin, Alain Buisson, Mireille Albrieux

    Excessive synaptic loss is thought to be one of the earliest events in Alzheimer’s disease (AD). However, the key mechanisms that maintain plasticity of synapses during adulthood or initiate synapse dysfunction in AD remain unknown. Recent studies suggest that astrocytes contribute to functional changes observed during synaptic plasticity and play a major role in synaptic dysfunction but astrocytes behavior and involvement in early phases of AD remained largely undefined. We measure astrocytic calcium activity in mouse CA1 hippocampus stratum radiatum in both the global astrocytic population and at a single cell level, focusing in the highly compartmentalized astrocytic arbor. Concurrently, we measure excitatory post-synaptic currents in nearby pyramidal neurons. We find that application of soluble Aβ oligomers (Aβo) induced fast and widespread calcium hyperactivity in the astrocytic population and in the microdomains of the astrocyte arbor. We show that astrocyte hyperactivity is independent of neuronal activity and is repaired by transient receptor potential A1 (TRPA1) channels blockade. In return, this TRPA1 channels-dependent hyperactivity influences neighboring CA1 neurons triggering an increase in glutamatergic spontaneous activity. Interestingly, in an AD mouse model (APP/PS1–21 mouse), astrocyte calcium hyperactivity equally takes place at the beginning of Aβ production, depends on TRPA1 channels and is linked to CA1 neurons hyperactivity. Our experiments demonstrate that astrocytes contribute to early Aβo toxicity exhibiting a global and local Ca2+ hyperactivity that involves TRPA1 channels and is related to neuronal hyperactivity. Together, our data suggest that astrocyte is a frontline target of Aβo and highlight a novel mechanism for the understanding of early synaptic dysregulation induced by soluble Aβo species.